Other
Chemotherapy
0
Pipeline Programs↗
144
Active Trials↗
52
Companies Involved↗
Chemotherapy is an early-stage landscape with 0 programs across 52 companies. The most active players are AstraZeneca, Amgen, GSK.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
522
clinical trials
Completed175 · 34%
Unknown status124 · 24%
Recruiting84 · 16%
Terminated62 · 12%
Not yet recruiting34 · 7%
Active, not recruiting26 · 5%
Other17 · 3%
Clinical Trials
Trial Activity
522 trials
POST URS Chemotherapy Instillation
Recruiting·—·N/A·NCT06167057·264 enrolled
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC
Recruiting·TThe First Affiliated Hospital with Nanjing Medical University·Phase 3·NCT05956639·100 enrolled
Page 1 of 35
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)